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Abstract
Background: The origin and clinical relevance of exercise-induced premature ventricular beats (PVBs) in patients
without coronary heart disease or cardiomyopathies is unknown. Cardiovascular magnetic resonance enables us to
non-invasively assess myocardial scarring and oedema. The purpose of our study was to discover any evidence of
myocardial anomalies in patients with exercise-induced ventricular premature beats.
Methods: We examined 162 consecutive patients presenting palpitations and documented exercise-induced
premature ventricular beats (PVBs) but no history or evidence of structural heart disease. Results were compared
with 70 controls matched for gender and age. ECG-triggered, T2-weighted, fast spin echo triple inversion recovery
sequences and late gadolinium enhancement were obtained as well as LV function and dimensions.
Results: Structural anomalies in the myocardium and/or pericardium were present in 85 % of patients with
exercise-induced PVBs. We observed a significant difference between patients with PVBs and controls in late
gadolinium enhancement, that is 68 % presented subepicardial or midmyocardial lesions upon enhancement,
whereas only 9 % of the controls did so (p < 0.0001). More patients presented pericardial enhancement (35 %) or
pericardial thickening (27 %) compared to controls (21 % and 13 %, p < 0.0001). Myocardial oedema was present in
37 % of the patients and in only one control, p < 0.0001. Left ventricular ejection fraction did not differ between
patients and controls (63.1 ± 7.9 vs. 64.7 ± 7.0, p = 0.13).
Conclusions: The majority of patients with exercise-associated premature ventricular beats present evidence of
myocardial disease consistent with acute or previous myocarditis or myopericarditis.
Keywords: Cardiovascular magnetic resonance , Myocarditis, Pericarditis, Premature ventricular beats,
Late gadolinium enhancement, STIR
Background
The origin and clinical relevance of exercise-induced
premature ventricular beats (PVBs) in patients without
structural heart disease such as myocardial infarction,
coronary artery disease, left ventricular hypertrophy,
cardiomyopathies or significant valvular disease is un-
known. From a traditional perspective, PVBs at rest in
individuals without structural heart disease are assumed
to be benign [1–4]. In contrast, more recent studies [5–8]
report that participants with frequent atrial or ventricular
premature beats at rest or exercise are at higher cardio-
vascular risk during follow-up. Some studies report no
predictive value in conjunction with the prognostic signifi-
cance of exercise-associated PVBs [9–11] whereas others
detect an association between PVBs during exercise and a
higher risk of cardiovascular or all-cause mortality rates
[5, 12, 13]. The underlying etiology of premature beats is
often unknown. LV function, dimensions, and flow param-
eters can be measured accurately by cardiovascular mag-
netic resonance (CMR) [14, 15]. Late gadolinium
enhancement (LGE) and oedema sequences (STIR) have
been performed in patients with acute or remote myocar-
ditis [13–21].
We hypothesized that patients with exercise-associated
premature ventricular beats would present evidence of
acute or remote myocarditis or myopericarditis.* Correspondence: info@praxis-jeserich.de
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We prospectively studied consecutive patients referred to
our department with palpitations and exercise-associated
premature ventricular beats. One hundred ninety con-
secutive patients who were transferred to our magnetic
resonance department with confirmed exercise-associated
ventricular ectopies were examined between 1.1.2008 and
30.11.2014 (end of recruitment period). The controls were
prospectively scanned and recruited if they were free of
atrial or ventricular premature beats and had no evidence
of structural heart disease as was examined by medical
history, echocardiography and exercise test before the
magnetic resonance scan.
Inclusion criteria for the patients were documented
PVBs during exercise treadmill test with a history of
palpitations, fatigue or exertional dyspnoea. Exercise-
associated PVBs were defined as one or more ventricular
ectopics during exercise including the first minute after
exercise. Patients were excluded if they had a history or
findings suggestive of or confirmed coronary artery dis-
ease (history of myocardial infarction, signs of ischemia
on stress tests, transmural scar on echocardiography or
subendocardial or transmural scars on magnetic res-
onance tomography), dilated or hypertrophic cardiomyop-
athy, congenital heart disease, pulmonary hypertension, LV
hypertrophy, significant valvular regurgitation or valvular
stenosis, renal failure (creatinine ≥1.8 mg/dl, GFR <30).
Further exclusion factors were: chronic alcohol abuse, use
of sympathomimetic drugs, Conn syndrome, chronic loop
diuretic treatment, chronic use of laxatives or any other
causes of hypokalemia.
Informed consent was obtained from each patient and
control, and the study protocol conforms to the ethical
guidelines of the 1975 Declaration of Helsinki as reflected
in a priori approval by the institution’s human research
committee. After exclusions, our final cohort comprised
162 patients whom we compared to 70 age- and sex-
matched controls without exercise-induced PVBs.
Cardiovascular magnetic resonance
All images were acquired on a 1.5 T magnetic resonance
system (Intera CV 1.5 T, Philips Medical Systems, Best,
the Netherlands) and specifically designed software (Re-
lease 11). We used a five-element cardiac phased-array
coil combined with a homogeneity correction algorithm
(Constant Level AppeaRance; CLEAR) [22]. Constant
level appearance is a homogeneity correction applied to
compensate for signal inhomogeneity attributable to the
surface coils. It is equivalent to a SENSE acquisition with
a SENSE factor of one to acquire the sensitivity maps for
each synergy coil element (relative to the body coil sen-
sitivity) that can be used to get a perfect uniformity cor-
rection [22].
Data acquisition was ECG-triggered. We took 2, 3 and
4-chamber long-axis views and 3-D short-axis volume
data assessed by steady-state free precession imaging
(field of view 350 mm, matrix 256 × 256, slice thickness
10 mm, no gap, echo time 1.6 ms, repetition time
4.0 ms, flip angle 60°) to evaluate LV function and di-
mensions. Phase-contrast velocity images in the ascend-
ing aorta were obtained to measure stroke volume and
rule out significant aortic insufficiency. Functional and
morphological data were evaluated using view forum
6.5. (Philips Medical Systems, Best, the Netherlands).
All patients underwent ECG-triggered, T2-weighted,
fast spin echo triple inversion recovery sequences (STIR)
in a short axis view covering the whole left ventricle
(seven to nine acquisitions, slice thickness 10 mm, no
gap, field of view 350 mm, matrix size 512 × 512, flip
angle 90°, echo time 100 ms, TR 2 RR intervals). We
measured signal intensity in the myocardial wall and
skeletal muscle. We draw five regions of interest into the
septum, five into the anterior, five into the lateral, and
five into the inferior wall of the myocardium. If the re-
gions were inhomogenous we draw five to 10 regions of
interests. This was only the case in 5 % of patients. Five
regions of interest were drawn into the skeletal muscles
(erector spinae muscle or lattissimus dorsi) with a
homogenous signal. Relative myocardial signal intensity
was calculated by the ratio of myocardial signal intensity
and muscle signal intensity. Resulting from our previous
study findings, we set the cut-off value of an elevated ra-
tio of signal intensity in STIR images between myocar-
dial and skeletal muscle was at 2.14 [20, 21, 23].
The homogeneity of the signal intensity of the region
of interest has been studied intensively at the start of the
pilot study in volunteers and patients. A very good ro-
bustness of the performed STIR sequence showing a
homogeneous signal at different time-points in the same
volunteers was found and a good inter- and intraobser-
ver variability was found [20].
Late gadolinium enhancement (LGE) imaging was ob-
tained in all patients 10 min after the iv. administration of
0.2 mmol/kg gadolinium-diethylenetriaminepentaacetate
using 3D inversion recovery turbo gradient echo sequences
(2 acquisitions, an inversion time 230 to 280 ms, field of
view 330 mm, matrix size 256 × 256, slice thickness 5 mm,
no gap, echo time 1,4 ms, TR shortest, flip angle 15°) were
optimized for each measurement to guarantee maximum
myocardial signal suppression. 3D volume of the left ven-
tricle was obtained covering the complete left ventricle
without gap during two breath holds. Pericardial en-
hancement was defined as local or diffuse contrast
enhancement. To exclude partial volume effects, peri-
cardial thickening and enhancement were obtained in
short and long axis views. Locally-thickened pericardium
was defined as ≥4 mm. All CMR analysis including STIR
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and LGE measurements were carried out by one experi-
enced CMR specialist who was blinded to the clinical
characteristics and history of patients and controls. Clin-
ical data were obtained and collected by our co-workers
and study nurse.
Statistical analysis
Data are presented as means and standard deviations for
quantitative variables and as absolute and relative frequen-
cies for categorical variables. Variables between patients
and controls were compared using t-tests for quantitative
and Chi-square-tests for categorical variables. All tests
were two-sided and used a significance level of 0.05 to in-
dicate statistical significance.
Results
Patient baseline characteristics are shown in Table 1.
Nineteen percent of our patients had exertional dys-
pnoea, 31 % precordial discomfort, 43 % fatigue and
weakness, and 61 % palpitations. Mean BNP values were
measured in 70 patients and were 67 ± 132 pg/ml, 6 pa-
tients had values above 100 pg/ml, one of these patients
had a value of 1010 pg/ml. Troponin values were ele-
vated in 3 patients. Control subjects did not differ re-
garding age and sex. Functional parameters are listed in
Table 2. Patients and controls had normal LV-function
and dimensions. The patients’ LV ejection fraction was
not significantly different from those of the controls.
Cardiac output was modestly higher in controls com-
pared to patients (Table 2). STIR measurements were
unavailable in six patients and five controls. Mean VES
frequency during exercise including the first minute
after exercise was 29.1 ± 69.1. Forty-one patients had
one or more couplets, 15 triplets or ventricular runs.
Oedema
Sixty out of 162 (37 %) patients displayed elevated T2-
weighted CMR (STIR) values indicating oedema (ratio of
signal intensity in STIR images between myocardial and
skeletal muscle ≥ 2.14) and 102 patients had normal values.
Figure 1 depicts one patient’s STIR image.
Table 1 Clinical characteristics of our 162 patients
Variable Patients
Mean age, years (SD) 57.4 (12.8)
Female (%) 54 (33)
Height, cm (SD) 174.8 (8.4)
Weight, kg (SD) 80.1 (13.9)
Systolic blood pressure (mm Hg, SD) 139.2 (18.8.)
Diastolic blood pressure (mm Hg, SD) 82.5 (10.1)
Potassium (mEq/L) 4.5 (0.6)
Palpitations (%) 98 (60.5 %)
Weakness, fatigue (%) 69 (42 %)
Dyspnea (%) 30 (18.5 %)
Precordial pain 50 (31 %)
Additional premature ventricular beats at rest 67 (41 %)
Standard deviation or percentage in parentheses







Heart rate, beats per minute 76.6 ± 16.7 71.8 ± 13.4 0.11
LV ejection fraction, % 63.1 ± 8.0 64.7 ± 7.0 0.13
LV stroke volume, ml 97 ± 17 97 ± 21 0.86
LV end-diastolic volume, ml 155 ± 34 153 ± 36 0.69
LV end-diastolic diameter, mm 51.1 ± 5 52.3 ± 4 0.08
Cardiac output, L/min 6.5 ± 1.5 7.0 ± 1.6 0.03
STIR of the left ventricular
myocardium
590 ± 112 536 ± 115 0.007
STIR of the skeletal muscle 294 ± 60 299 ± 54 0.64
STIR myocardium/skeletal muscle 2.0 ± 0.3 1.8 ± 0.3 0.001
Contrast enhancement, % 67.9 8.5 <0.0001
LV indicates left ventricular. Values are expressed as mean ± standard deviation
STIR: T2-weighted, fast spin echo triple inversion recovery sequences. Values
are expressed as mean ± standard deviation
Fig. 1 An exemplary T2-weighted (STIR) image of a 57 year old
female patient with a viral respiratory viral infection 3 weeks ago
and exercise induced PVBs. Globally enhanced signal intensity of
the myocardium of the left ventricle (arrows) compared to skeletal
muscle. The ratio of signal intensity between myocardial and skeletal
muscle was elevated (2.26). LV: Left ventricle. RV: Right ventricle.
SM: Skeletal muscle
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There was no significant difference in either LV-
function or LV-volumes (EF 62.6 ± 7.9 % vs. 63.4 ± 7.9 %,
p = 0.53, left ventricular enddiastolic volume 153 ± 35 ml
vs. 156 ± 33 ml, p = 0.62) between patients with and
without oedema. One control revealed a modestly-elevated
STIR ratio but no symptoms.
Contrast enhancement
Contrast enhancement was present in the myocardium
of 110/162 patients and only in 6/70 controls (p < 0.0001,
Table 2). Regions of contrast enhancement were usually
patchily distributed and originated primarily from the epi-
cardial quartile or midmyocardial wall location, with one
or several foci within the myocardium usually located in
the septum and lateral free wall, less often in the inferior
or anterior areas. Figure 2a/b depict an example of one
patient. The location was septal in 45 %, lateral in 27 %,
septal and lateral in 9 % of all patients. Figure 3 presents
the late-enhancement image of a 59-year-old female with
a long-lasting respiratory tract infection and septal and
lateral foci. Five patients presented inferior and one pa-
tient apical distribution. Thirty-five percent of all patients
displayed mild-to-moderate pericardial contrast enhance-
ment, usually distributed locally in the lateral or anterolat-
eral part of the pericardium, compared to 21 % of the
controls, p < 0.001. Twenty-seven percent of the patients
presented locally-thickened pericardium (≥4 mm) pri-
marily in the lateral or anterolateral parts of the peri-
cardium, compared to 13 % of the controls, p < 0.001.
Minor, not hemodynamically-relevant pericardial effu-
sions were present in 18 % of patients and in 3 controls.
The controls’ effusions were small enough as to be invis-
ible on echocardiography.
Twenty-three patients revealed no myocardial or peri-
cardial anomalies, whereas we detected myocardial or
pericardial anomalies in 85 % of patients with exercise-
induced PVBs.
Discussion
The present study provides evidence of myocardial
anomalies in the vast majority of patients with exercise-
associated premature beats. Eighty-five percent of our
patients presented signs of acute or remote myocarditis
or myopericardits despite having normal LV function.
About two-thirds of our patients presented a subepicar-
dial or/midmyocardial late contrast-enhancement typical
of myocarditis [18, 19, 24, 25]. In addition, about a third
of patients displayed hints of pericardial involvement
such as pericardial enhancement, local thickening or
small pericardial effusions. Moreover, about a third of
our patients presented myocardial oedema. This could
have important clinical consequences, since patients
with exercise-induced ventricular arrhythmias and myo-
cardial oedema can be at risk for sudden cardiac death
during exercise [26].
Some studies of the prognostic significance of ven-
tricular arrhythmia during exercise have assumed that
PVBs are benign [9–11], whereas others detected an asso-
ciation between PVBs and greater risk of cardiovascular or
all-cause mortality rates [5, 12, 13]. There is recent evi-
dence that frequent PVBs may be involved in the patho-
genesis of heart failure in patients with LV dysfunction
[27, 28] and that some patients with initially-normal LV
function developed a reduction in ejection fraction during
an observation period lasting five to six-years [2]. In
our study, patients and controls displayed normal LV
function but it is well known that some patients with
myocarditis develop dilated cardiomyopathy over the
following years [29, 30] that may explain their elevated
future risk.
Sudden cardiac death in athletes [31] and in the gen-
eral population is not infrequently due to undiagnosed
myocarditis [32, 33]. It has long been known that in-
creased sympathetic nerve activity during physiologic
stress (exercise, swimming, emotion, arousal, loud noise,
Fig. 2 a/b Late-enhancement image of one patient with exercise induced PVBs. Note the patchy enhancement of the midwall septal (↑) and
lateral wall (↑↑). Four and two-chamber view. LV: Left ventricle. RV: Right ventricle
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etc.) has profound influence on the heart’s electrical and
contractile functions. In the predisposed heart, these
stressors may lead to ventricular tachyarrhythmias and
sudden death [34]. The extrasystoles observed in our
study during exercise testing may also occur during daily
activities involving exertion, exercise, or during athletic
activities. It is hypothesized that the higher risk of car-
diovascular or all-cause mortality in patients with PVBs
observed in some studies [5, 12, 13] might be due in part
to higher rates of sudden cardiac death. It is thus
important to reveal any underlying etiology that might
predispose patients to risk. The myocardial oedema
observed in 37 % of our patients may be just such a pre-
disposing factor. CMR is considered an important diag-
nostic tool for myocarditis [18], and an increased signal
in T2-weighted images is a typical finding in patients
with acute myocarditis [17, 20, 23, 35, 36] Usually,
oedema is located in the ventricular wall’s epicardial
layer during the acute phase of focal myocarditis. It is
reasonable to assume that ventricular ectopic beats may
be generated in these areas.
LGE has been investigated in controlled studies with
patients suspected of having myocarditis [17, 35, 37]. It
revealed a typical subepicardial or midmyocardial late
contrast-enhancement pattern. In our study, regions of
contrast enhancement showed a pattern typical of non-
ischemic injury with subepicardial or midmyocardial dis-
tribution that ranged from one to several foci, and from
almost normal to diffusely-enhanced myocardium. The
predominant areas were the septum and lateral free wall,
consistent with other reports [35, 38]. We observed no
contrast enhancement involving the subendocardial layers
as would be typical for myocardial infarction, supporting
the presumption of a chronic degenerative or inflamma-
tory process as a cause of the contrast enhancement.
Pericardial effusion has been reported in 32 to 57 % of
patients with myocarditis [39–41]. A quarter of our pa-
tient cohort had very small pericardial effusion, support-
ing the notion of pericarditis accompanying myocarditis.
This is further strengthened by our having detected mild
to moderate contrast enhancement of the pericardium
and locally-thickened pericardium in about 30 % of our
patients, findings typical of pericarditis [41, 42].
The aforementioned working groups [5, 9–13] did not
address the origin of the PVBs. We observed oedema
and/or scar as a pathological substrate in most of our
patients. Other potential sources of PVBs such as hyper-
trophy, renal insufficiency, valvular heart disease, or car-
diomyopathies were also ruled out by our exclusion
criteria. Our patients presented no clinical evidence of sys-
temic disorders like sarcoidosis or muscular dystrophy in
which LGE may also be present [43, 44]. We observed no
evidence of long-QT syndrome, catecholaminergic poly-
morphic ventricular tachycardia, early repolarisation or
brugada syndromes which would have revealed prognostic
information for the patient [45]. 4 Thus, our study provides
evidence that exercise-associated ventricular arrhythmias
may be caused by acute or previous inflammatory tissue
injury or underlying chronic structural heart disease.
Conclusions
We conclude that the majority of patients with exercise-
associated premature ventricular beats present evidence
of myocardial disease consistent with acute or previous
myocarditis or myopericarditis.
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